All drug trials of the Alzheimer's disease (AD) have failed to slow the progression of dementia in phase III studies, and the most effective therapeutic strategy remains controversial due to the poorly understood disease mechanisms. For AD drug design, amyloid beta (Aβ) and its cascade have been the primary focus since decades ago, but mounting evidence indicates that the underpinning molecular pathways of AD are more complex than the classical reductionist models.
Glossary:
AD = Alzheimer's disease; APP = Amyloid precursor protein; GWAS = Genome-wide association study; FAK = Focal adhesion kinase; PSD = Postsynaptic density; PSEN1/2 = Presenilin1/2; SFK = Src family kinase
Introduction
More than a century has passed since the first report of a presenile dementia case by Alois Alzheimer 1 , and the current understanding of AD pathophysiology borrows from identification of the Aβ peptide as the main constituent of senile plaques and subsequent discovery of APP and PSEN mutations in rare familial forms of AD 2,3 . These observations were compiled to the amyloid cascade hypothesis in the pre-genomic era 4 , which remains the central theory of AD etiopathogenesis and implicates Aβ and neurofibrillary tangles as the causes of disease.
Nevertheless, due to methodological difficulties, Aβ species has hardly been validated as the causal force of neurodegeneration in humans. Despite the general support received from preclinical models, manipulating pathways of Aβ generation and clearance has yielded disappointing results in several clinical trials so far 5 . While a handful of clinical failures do not necessarily warrant disproval of a theory per se, overemphasis on a single disease model is a dangerous gamble and could be one of the many explanations for the lack of progress in AD therapeutic design 6 .
Accuracy of the amyloid cascade hypothesis is a topic of ongoing debate [7] [8] [9] [10] [11] [12] , and the longstanding over-reliance on a potentially wrong model warrants development of independent mechanistic explanations for this prevalent cognitive disorder. For this aim, the novel genomewide insight into AD risk loci provides a strong basis, since in contrast to the neuropathological hallmarks including senile plaques and neurofibrillary tangles, which are of questionable etiological significance 13 , genetic risk factors temporally precede earliest stages of brain development, aging, and degeneration, and are expected to inform on causal events in the disease cascade.
Genetic architecture of common late-onset AD is highly multifactorial and only partly understood. Although a number of susceptibility loci have been identified by genome-wide association studies [14] [15] [16] [17] [18] [19] , mechanistic interpretation of these new observations have generally been under powerful influence of the amyloid cascade theory so far. In contrast, our report servers to provide an evidence-based framework for compiling the genetic pathways of AD within an Aβ-independent domain. The rest of this manuscript is organized as follows; in the first section, I aim to comprehensively revisit roles of classical and novel genetic modifiers of AD risk in pathways of normal cell physiology. I show that APP, presenilins and APOE as well as 23 other AD risk genes converge to common pathways of cell-extracellular adhesion signaling, with important implications in synaptic circuit formation and neurite outgrowth navigation. In the second section, I provide bioinformatics evidence for interaction of aging with this genetic landscape by showing that even the insidious "normal" rate of DNA damage in aging cells may disproportionately hamper synthesis of extremely large synaptic adhesion proteins in late life. Finally, several immediately testable predictions are provided for assessment of this new disease model.
The APP family genes encode evolutionarily-conserved cell adhesion proteins
Derailed catabolism of the APP protein and generation of an aggregation-prone Aβ species abstract the mainstream theory of AD pathophysiology, and several efforts have been made to block this cascade by means of Aβ immunotherapies or design of secretase inhibitors 5 . In contrast, three decades after successful cloning of the APP gene 20 , the potential physiological roles of its protein product remain under-explored and unknown.
APP codes for a single-pass transmembrane protein and shows high expression levels at the site of neuronal growth cones, structures that form motile tips of the outgrowing axons and dendrites in the developing brain 21 . The Aβ peptide enhances interaction of neurites with extracellular adhesion molecules and promotes elongation of cell membrane projections 22, 23 . The full-length and membrane-tethered form of the APP protein also interacts with the extra-cellular matrix adhesion molecules including laminin, heparan sulfate, fibronectin and collagen [24] [25] [26] . More specifically, interaction of APP with laminin 24 and heparan sulfate 27 has neurite-promoting effects, and this protein stimulates assembly of hippocampal connections 28 . On the other hand, antisense-downregulation of APP inhibits extension of neurites 29 . APP demonstrates a dose-effect in affecting growth cone adhesion and guidance 30 . Increased dosage of APP in Down syndrome results in emergence of faster advancing growth cones with promoted adhesive properties and larger sizes 31 . In contrast, knockdown of the APP gene in zebrafish results in neurite outgrowth disruption 32 . Intriguingly, although wild-type human APP can rescue this abnormal phenotype, the mutated APP gene of familial AD fails to substitute for the normal function of animal gene 32 .
Several intracellular pathways are speculated to mediate the neurite-promoting effects of APP in neuronal membrane. The netrin pathway of neurite guidance incorporates APP as a co-receptor for cell signaling 33 . In this context, APP inactivation disrupts normal netrin signaling and diminishes axonal outgrowth 34 . APP also binds the extracellular reelin glycoprotein, which is a large adhesion molecule for guidance and migration of neurons 35 . Interaction of reelin with APP promotes outgrowth of hippocampal neurites 35 , and this functional interaction requires presence of another cell adhesion molecule, the α 3β1-integrin, as well 35 . Of note, integrin receptors are the main component of focal adhesion complexes, and they co-localize with the APP protein 36,37 at dynamic neuronal adhesion sites 38 . In line, interaction of integrin with APP modulates neuritic outgrowth 39 . Integrin also acts as an accessory reelin receptor for cell adhesion modulation and neuronal migration [40] [41] [42] , and therefore they functionally link two important AD risk genes, including APP and the APOE receptor pathway as shall be discussed later.
In addition to influencing growth cone movement, the APP protein also coordinates spatial migration of neurons during brain development 43 . Triple-knockout of the APP family genes in mice results in a neuronal migration defect similar to human lissencephaly 44 . Further implicating a potential role in cell migration, two candidate extracellular ligands of the transmembrane APP protein including pancortin and lingo1 orchestrate migration of neural precursor cells [45] [46] [47] . It is noteworthy that pathways of growth cone adhesion and cell movement are mechanistically convergent, since both of these biological motility events rely on specialized membrane protrusions, namely filopodia and lamellipodia, for changing extracellular adhesion forces and cell membrane reshaping. These membrane projections possess surface adhesion receptors, which control dynamic rearrangement of the intracellular actin cytoskeleton for changing cell polarity, shape and movement direction 48 .
In close homology to canonical pathways of cell adhesion, mounting evidence indicates that the cytoskeletal system is an important point of convergence in the APP signaling axis. Transmembrane APP is selectively localized to the cytoskeletal-rich regions of neuronal growth cones at dynamic adhesion sites 38, 49 , and the APP intracellular domain (AICD) reportedly affects rearrangement of the cellular actin cytoskeleton 50 . In this context, AICD interacts with a number of intracellular signal transducers, including Fe65, Tip60, KAI1, DISC1, dab1, X11, and Grb2 [51] [52] [53] . All of these signal transducers influence pathways of cytoskeletal rearrangement and cell movement in diverse cellular mechanisms spanning cancer cell migration and brain development:
• Fe65 and Tip60 affect the cytoskeletal system and moderate cancer cell migration 54 .
• KAI1 suppresses cancer cell migration by influencing cytoskeletal assembly 55, 56 .
• DISC1 coordinates remodeling of the actin cytoskeleton in migrating neurons and growth cone-like protrusions 57 . Of note, this protein rescues neuronal migration defects caused by loss of the APP gene 51 .
• Dab1 is a mandatory adaptor of the lipoprotein receptors axis in the APOE/reelin signaling pathway and controls remodeling of the actin cytoskeleton in neuronal migration 58 .
• X11 is a recently discovered modulator of the reelin pathway and affects cell movement 59 .
• Grb2 is an adaptor molecule which links various receptors including integrins with intracellular pathways of cytoskeletal plasticity, and thereby regulates cancer cell migration 60, 61 .
In line, there is also ample evidence for functional engagement of the APP family proteins in migration and invasion of various cancer cells through the cytoskeletal pathway 62, 63 . Through a feedback-like mechanism, the cytoskeletal regulator Rac1 controls expression of the APP gene in primary hippocampal neurons 64 . This functional engagement in cell migration has probably been evolutionarily conserved, as the APP gene paralogue of Drosophila (APPL) has promoted the neuronal migration process since the earliest stages of nervous system evolution 65 . In line, phylogenetic evolution suggests that cell adhesion is the most consistent biological function of the APP family genes 66 .
The cytoplasmic tail of APP is noteworthy in the evolutionary context, since it comprises a super-conserved NPxY amino acid motif in the form of 682 YENPTY 687 which has remained unchanged from roundworms to humans for more than 900 million years 67 . This consensus motif is known to mediate endocytic sorting of membrane receptors and their interaction with intracellular tyrosine-phosphorylated signaling adaptors 68 . Two mentioned intracellular adaptors of the APP protein, including dab1 and Fe65, interact with this consensus motif in a phosphorylation-dependent manner 69, 70 . Further implicating a signaling role, the 682 Tyr residue of this APP motif undergoes phosphorylation and is essential to synaptogenesis 71 .
In addition to neurodevelopmental roles, the APP protein is also evidenced to maintain its function in mature neurons. Mouse hippocampal neurons express the APP protein under physiological conditions 72 , and APP is present in close proximity to post-synaptic NMDA glutamate receptors. APP controls postsynaptic trafficking of these synaptic receptors and promotes neurotransmission 73, 74 . Through its conserved NPxY motif, APP also interacts with the postsynaptic scaffold protein AIDA-1 75 , which is a regulator of synaptic transmission and palsticity 76 . On the other hand, loss of the APP family genes disrupts synaptic function 77 , memory formation 78 , and causes an aging-related synaptic loss in mice 79, 80 . APP and the other two members of this protein family form trans-synaptic adhesion dimers 81 . Cleavage of the APP protein changes synaptic adhesion and assembly 82 , and mutations in APP disrupt synaptic adhesion 83 . A more detailed review of the APP protein and its roles in neurophysiology is beyond the scope of this manuscript and the interested reader is referred to recent publications 84-86 . 1.2 The γ -secretase complex is a membrane-tethered enzyme for signaling of cell adhesion receptors PSEN1 and PSEN2 genes code for catalytic subunits of the transmembrane γ -secretase enzyme, and various mutations in these genes underpin autosomal-dominant forms of AD. As a mandatory step in Aβ 40/42 generation, γ -secretase cleaves the APP protein at the γ -site. However, as a surprising finding, it was recently observed that some PSEN mutations of familial AD cause an almost complete loss of γ -secretase function 87 and reduce generation of the putativelyneurotoxic Aβ 40 , Aβ 42 and Aβ 43 species occasionally to undetectable levels 88, 89 . In further contradiction, when knock-in mouse models were constructed using the mutated PSEN1 gene of familial AD, they were phenotypically similar to knockout strains lacking any γ -secretase function, with both of these strains demonstrating impaired hippocampal plasticity 90 . This novel line of evidence reinforces a loss-of-function impact for the PSEN mutations of familial AD, and may explain the paradoxical worsening of cognitive function and accelerated brain atrophy in the γ -secretase inhibitor trials of AD 91, 92 .
In contrast to the narrow focus on derailed pathways of APP catabolism, unbiased proteomic profiling reveals that the γ -secretase enzyme has a broad spectrum of substrate specificity to molecules with transmembrane signaling roles 93, 94 108 . For instance, the two lipoprotein receptors of the reelin pathway are shared with APOE, including APOEr2 and VLDLr receptors. Activation of these receptors by reelin triggers phosphorylation of the intracellular dab1 adaptor, which binds to the consensus NPxY motif of the receptor intracellular domain 109 . Through dab1 activation, the reelin pathway affects various aspects of cell physiology, among which cytoskeletal remodeling and neuronal migration are central 110 . Importantly, the reelin pathway guides extension of hippocampal neurites 111 and coordinates outgrowth of the perforant path which forms the major input fibers to the hippocampal formation 112 .
The APOE molecule shares its lipoprotein signaling receptors with reelin 113 , and mounting evidence indicates that APOE also undertakes a similar role in guiding outgrowth of developing neurites [113] [114] [115] [116] [117] . The neurite promoting effect of APOE is isoform-dependent, with the APOE3 isoform being a more potent neurite outgrowth inducer than the APOE4 risk isoform 115, 117 .
Unlike reelin, the intracellular signaling pathway of the APOE molecule has been less investigated in neurons, but partly studied in other cells. In macrophages, APOE activates transducers of the reelin pathway including dab1 and PI3K 118 . In vascular pericytes, APOE affects rearrangement of the actin cytoskeleton and its knockdown deranges normal cell migration 119 . The APOE4 isoform also affects the proteomic signature of cytoskeletal regulators in peripheral nerves 120 . Taken together, this body of evidence suggests that the APOE molecule may signal through a reelin-like network by incorporating lipoprotein receptors and the cytoskeletal system for inducing cell adhesion and movement.
In addition to the strong association of the APOE locus with AD, other risk loci further reinforce relevance of lipoprotein receptors and their signaling path in this disease. Variants within the reelin gene are the top genetic correlate of AD-type neuropathology in postmortem human brains 121 . F-spondin (Spon1), which codes for a reelin domain-containing cell adhesion molecule, is correlated with the rate of cognitive decline in AD and also affects white matter microstructure in healthy humans 122, 123 and activation of the lipoprotein receptor pathway by reelin promotes synaptic plasticity [134] [135] [136] . Specifically, a recent study shows that postsynaptic activity of APOEr2 is critical for dab1 phosphorylation and insertion of AMPA glutamate receptors at postsynapse for long-term potentiation 137 . Lipoprotein receptors also share several intercellular signal transducers with the APP protein, including X11, dab1, and Fe65 133, 138 , potentially reflecting convergent signaling pathways.
1.4 AD susceptibility loci strongly implicate cell adhesion pathways Familial early-onset AD which is caused by APP or PSEN mutations constitutes less than one percent of diagnosed patients. In contrast, several genome-wide association studies have recently revealed the complex polygenic landscape of common late-onset AD [14] [15] [16] [17] [18] [19] . Remarkably, the majority of late-onset AD risk genes engage in pathways of cell adhesion, migration and contactguidance:
• DSG2 (Desmoglein-2, rs8093731) is a component of desmosomal cell adhesion complexes. DSG2 gene product interacts with β 8-integrin and serves focal adhesion roles in endothelial cells and regulates cytoskeletal assembly 139 . DSG2 also controls cell motility, and its depletion affects migration of malignant melanoma cells 140 .
• EPHA1 (rs11771145) codes for a member of the ephrin-A receptor family of neurite adhesion and guidance. EPHA1 moderates cell migration through integrin-linked kinase and the cytoskeletal remodeling pathway 141, 142 . EPHA1 also affects invasion and metastasis of colorectal cancer cells 143 .
• FRMD4A 144 and FERMT2 (Kindlin-2, rs17125944) code for two members of the FERM domain family, which link integrin and focal adhesion kinase (FAK) with the intracellular actin cytoskeleton 145, 146 . FERMT2 transduces cell adhesion signals and is engaged in malignant cell invasion 147 .
• GAB2 (rs2373115), one of the earliest AD susceptibility loci to be discovered by genome-wide scan 14, 148 , encodes a scaffolding protein acting downstream to the integrin signaling pathway. GAB2 regulates adhesion and migration of hematopoietic cells 149 and also controls cytoskeletal remodeling in migrating breast cancer cells 150 .
• CASS4 (Hepl, rs7274581) 194, 195 . Taken together, the genetic architecture of AD strongly implicates various cell adhesion regulators and pathways of cytoskeletal plasticity. Further aiding in formulation of a unified disease model, many of these gene products cross-talk with the integrin pathway of focal adhesion. This convergence also strongly spotlights the Aβ-independent roles of the APP protein, γ -secretase and the APOE receptors in cell adhesion regulation and synaptic function.
The hypothesis
By using the unbiased genetic architecture of AD, our model puts the cell adhesion process at the center of disease pathways. Focal adhesion regulators including integrins coordinate cell migration, neurite outgrowth, and assembly of synaptic circuits in brain development. In the post-developmental brain, these canonical pathways also undertake pivotal roles in maintaining synaptic adhesion and plasticity
196
. Synaptic adhesion molecules form a dense scaffold at the postsynaptic density (PSD) sites and dendritic spines. This scaffold connects neurotransmitter receptors and ion channels with the intracellular actin cytoskeleton as well as the extracellular matrix, aiding in synaptic maintenance and dynamic remodeling.
Synaptic adhesion molecules also act as mechano-chemical sensors and actively moderate trafficking of neurotransmitter receptors 197 . For instance, it has been shown that enhancing signaling of the synaptic integrin receptors by application of an agonist peptide modulates neurotransmission 198 in a dose-dependent manner 199 . In this context, integrin affects rearrangement of the actin cytoskeleton and promotes budding of filopodia -structures that strengthen synaptic connections 200 . Remarkably, this is the same mechanism through which the integrin pathway coordinates growth-cone adhesion and pathfinding during synaptic circuit development 201 . It is noteworthy that the post-developmental role of cell adhesion pathways in synaptic physiology is not limited to integrins, and has been observed for several cell adhesion molecules (Fig. 1) .
I propose that the heritable component of AD is determined by genetic factors which coordinate growth cone adhesion and assembly of synaptic circuits in brain development. The same molecular machinery also takes part in post-developmental synaptic maintenance, plasticity and 1 1 Figure 1 . Biological adhesion pathways transfer extracellular signals across the cell membrane, and affect cell polarity, movement and survival (top). Various pathways of extracellular adhesion signaling coordinate rearrangement of the actin cytoskeleton and thereby control reshaping of membrane projections for cell movement and plasticity (bottom). FAK: focal adhesion kinase; LRP: lipoprotein receptor; Shh: Sonic hedgehog. 202 , and these mutations may represent the final outcome of a broader DNA damage process. Loss of genomic integrity is one of the factors already implicated in AD etiopathogenesis, but its relevance to molecular disease pathways has not been elucidated 12, 203, 204 .
From a statistical point of view, even if a fully random process causes accumulation of mutations in aging neurons, larger genes are expected to be disproportionately affected in late life. Suppose that the burden of 37 annual mutations is uniformly scattered at purely random genomic positions in neurons (5.7×10
-9 mutations/base pair.year). In this scenario, approximately 1% copies of a median-sized human gene (29.6kbp) will acquire at least one somatic mutation in a 65-year individual. In sharp contrast, the largest known human gene, CNTNAP2, which codes for a synaptic adhesion protein and is more than 80× larger than the median-sized gene, is expected to be highly vulnerable to somatic mutations, and only 42% of its copies are estimated to remain intact in the same individual (Fig. 2) . This high variability in the risk of mutations is due to the statistical distribution of gene sizes, which spans three-orders of magnitude with a long tail encompassing extremely large genes (Fig. 3) . Figure 2 . A simple binomial model in which somatic mutations take place at a fixed and uniform rate across the genome reveals that a median-sized human gene mostly survives the mutational burden of aging, with only ~1% of its copies being affected by any somatic mutation in a 65 year-old subject. However, larger genes will have a significantly shorter half-lives set at the 6 th and 7 th decade of life; many of these large genes regulate synaptic adhesion and function with relevance to neurodegenerative disorders, and also act as fragile tumor suppressors. Why has the evolution in some cases selected for extremely large genes, although they are known to map to chromosomal fragile sites 205 and possibly be more vulnerable to DNA damage? I was compelled to objectively investigate whether large human genes non-randomly take part in certain biological themes, cellular functions, and tissue types for a potential explanation of their exceptional evolutionary trajectory. For this aim, I size-sorted all of the protein-coding human genes (n=19,287 RefSeq genes that successfully mapped to DAVID indices), and considered the gene length threshold of >500kb for defining large human genes. This cut-off threshold resulted in consideration of 260 large human genes representing 1.3% of all protein-coding transcripts. Functional annotation profile, pathway enrichment, and tissue expression of this gene set of interest were investigated using a standard DAVID query 206, 207 .
Interestingly, the top overrepresented organs label for selective expression of these large genes were brain (p=1.4×10 -19 ), followed by amygdala (p=3.1×10 -5 ), and hippocampus (p=6.6×10 -5 ). By showing strong enrichment statistics, homophilic cell adhesion via plasma membrane adhesion molecules was the most overrepresented biological process related to this gene set of interest (Table 1) , and the most overrepresented cellular component was postsynaptic membrane (Table 2 ). All other enriched gene ontology terms further implicated pathways of nervous system development and physiology (Table 1) . Among KEGG curated biological pathways, four pathways were found to be statistically enriched, including Glutamatergic synapse (hsa04724; corrected p=0.02), Axon guidance (hsa04360; corrected p=0.03), Cell adhesion molecules (hsa04514; corrected p=0.04), and Insulin secretion (hsa04911; corrected p=0.04).
The strong selectivity of large human genes to brain, synapse and cell adhesion process is an enlightening observation, and I suggest that it may reflect existence of specialized natural selection forces for driving complexity of cognitive function in the evolutionary trajectory of organisms; these exceptionally large genes may have fostered adhesion and assembly of complex synaptic circuits in brain evolution. However, while larger genes may have promoted brain complexity, as an evolutionary bottleneck, they may also be inherently costlier to be maintained in late life due to limited DNA repair mechanisms, and such large synaptic genes may put modern humans at a neurobiological disadvantage when the burden of DNA damage is accumulated during the longer lifespan of modern humans. Importantly, since the average human life expectancy passed the 40-year milestone only two centuries ago 208 , there has been very weak evolutionary force for correcting the dementia-causing genomic variations. Taken together, rapid increase of brain complexity in parallel with extension of life expectancy may have recently unmasked a DNA maintenance and repair bottleneck in modern humans, which eventually presents as AD and potentially some other forms of senile disorders. 212 .
• Lrp1b is the largest member of the lipoprotein receptor family genes and at an extreme size of 1.9Mbp is the 8 th largest human gene overall. Potentially due to its size and mapping to the chromosomal fragile site FRA2F, Lrp1b is among the ten most frequently deleted genes observed in a study of 3,131 cancer specimens 213 .
• The Lrp1b gene product controls focal adhesion, cytoskeletal remodeling and cell migration 214, 215 , pathways which align with the genetic architecture of AD. Lrp1b is also cleaved by the γ -secretase enzyme and its intracellular fragment affects cell anchorage and survival 216 .
• Genetic variants of the Lrp1b locus are correlated with cognitive function in aging and AD 217, 218 . I predict that AD-type cognitive decline is correlated with propagation of DNA damage and somatic mutations in certain synaptic genes including Lrp1b, and subsequent dysfunctions in their intracellular pathways involving synaptic adhesion and maintenance. Although previous models have already implicated oxidative stress and DNA damage mechanisms in AD 12, 203, 204, 221 , high-throughput results do not support an oxidative etiology for the observed mutations. Oxidative stress typically causes G:C→T:A transversions due to formation of free radicals 222, 223 .
However, aging cells demonstrate a clock-like signature of somatic mutations with enrichment of C:G→T:A transitions 224, 225 . Intriguingly, this fingerprint was recently observed as the dominant type of mutations in neurons 223, 226, 227 . The reason for aging-related preponderance of C:G→T:A transitions is currently unknown, but spontaneous cytosine deamination, transcriptional stress, and failure of certain DNA repair mechanisms including base and nucleotide excision repair are potential explanations 228 .
It is noteworthy that Lrp1b only serves to provide one example of vulnerable synaptic genes in brain aging, and the true genetic landscape of AD and senile neurodegenerations is probably not reducible to the lipoprotein receptor axis (Fig. 6 ). Similar to loss of different tumor suppressor genes in various cancers which is caused by diverse DNA damage mechanisms, brain-wide expression of several unstable synaptic genes may underpin dementia heterogeneity in aging humans. For instance, the genome-wide landscape of the Parkinson's disease implicates several genes of the synaptic vesicular trafficking system, including the extremely large tumor suppressor PARK2 mapping to the chromosomal fragile site FRA6E 229 . In this regard, dopaminergic neurons of substantia nigra are the most vulnerable structures in Parkinson's disease, and they can be distinguished by selective expression of two tumor-suppressor genes with cell adhesion roles, including DCC 230 and AJAP1 231 . 
Future perspectives
Mice with distal truncation of Lrp1b have no apparent phenotype 131 , but a more proximally truncated Lrp1b causes early embryonic lethality 232 . Intriguingly, conditional knockout of the Lrp1 gene with 52% amino acid similarity to Lrp1b results in neurodegenerative changes in animals after 12 months of aging 233 . Conditional knockout of the Lrp1b gene and other modulators of the reelin/lipoprotein receptor signaling axis after completion of brain development may aid in modeling AD-type synaptic loss in animals.
Since even the most aggressive forms of AD remain clinically silent for decades, accelerating the aging process in laboratory animals may be necessary, for instance by crossing AD models with transcription-coupled DNA repair defective strains 234 or usage of mutagenic forces such as UV radiation. ar es es he Our hypothesis is not based on any form of etiological relevance for Aβ species, amyloid plaques or neurofibrillary tangles in causal disease pathways, and redefines these pathological features as bystander epiphenomena. Even the strong APOE risk locus of sporadic AD fails to explain ~94% of the disease variance. Therefore, single pathway therapeutic approaches may provide limited benefit in clinical trials.
In conclusion, this proposal, the large gene instability hypothesis, implicates DNA damage accumulation and loss of fragile synaptic adhesion genes as the primary etiology of AD. A shift of paradigm is warranted in AD drug design from manipulating the protein aggregation process to genetic engineering strategies such as large capacity gene therapy vectors. . . a  t  e  s  t  h  e  i  n  t  e  r  a  c  t  i  o  n  w  i  t  h  F  e  6  5  .  F  E  B  S  L  e  t  t  2  0  1  1  ;  5  8  5  :  3  2  2  9  -3  5  .  1  3  9 . . 
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